Pfizer ships Trumenba meningitis vaccine
Pfizer Inc. has released Trumenba, a meningococcal group B vaccine, to pharmacies and other health care providers in the United States.
CDR
Lannett chief compliance officer to retire
Pharmaceutical industry veteran Ernest Sabo plans to retire from Lannett Co. next year. The generic pharmaceutical company said late Monday that Sabo, vice president of regulatory affairs and chief compliance officer, is slated to retire effective Jan. 2, 2015.
Teva Canada launches Celebrex generic
Teva Canada Ltd. has released a generic version of Pfizer Inc.’s arthritis pain drug Celebrex (celecoxib). Teva said Monday that its generic celecoxib product, approved by Health Canada, is available now in pharmacies across Canada.
Revlon adds tagline in global brand relaunch
Cosmetics and beauty care giant Revlon Inc. has relaunched its brand with a global tagline, its first in more than a decade.
P&G executive named to chair CHPA
Patrick Lockwood-Taylor, vice president of personal health care for North America and digestive wellness design at Procter & Gamble Co., has been elected as chairman of the Consumer Healthcare Products Association (CHPA).
Cetaphil updates labeling for RestoraDerm line
Galderma Laboratories has unveiled a new look for its Cetaphil RestoraDerm line of eczema-soothing products.
Actavis acquires Allergan
Actavis PLC is acquiring Allergan Inc. in a transaction valued at about $66 billion. The combination will create one of the top-10 global pharmaceutical companies by sales revenue, with combined annual pro forma revenues of more than $23 billion anticipated in 2015.
FDA informs Kremers Urban of ADHD drug reclassification
The Food and Drug Administration is reclassifying methylphenidate hydrochloride extended-release tablets from Kremers Urban Pharmaceuticals Inc. as the agency seeks more bioequivalence information.
Berkshire Hathaway to buy Procter & Gamble’s Duracell
Conglomerate Berkshire Hathaway Inc. has agreed to acquire the Duracell battery business from Procter & Gamble Co. The companies said Thursday that the deal, encompassing roughly $6.
Telehealth provider HealthSpot draws investment from Xerox
Information and imaging technology giant Xerox is making an investment in telehealth provider HealthSpot Inc.
Kirby Lester pill counter sales rise after hydrocodone reclassification
Kirby Lester reported a spike in sales of its KL1 and KL1Plus tablet counters in October following the Drug Enforcement Agency’s reclassification of hydrocodone combination products to Schedule II. Kirby Lester KL1 (left) and KL1Plus tablet counters.
Mirixa appoints chief technology officer
Aaron Loutsch has been promoted to senior vice president and chief technology officer (CTO).
Lilly ships Trulicity to pharmacies
Eli Lilly and Co. has released Trulicity, a once-weekly treatment for type 2 diabetes, to U.S. pharmacies. Lilly said Monday that Trulicity (dulaglutide) comes in a single-dose pen, in 0.75 mg and 1.5 mg doses, and doesn’t require patients to mix, measure, or handle the needle.
Jolen unveils new package design for creme bleach
Jolen Inc. has rolled out a new look for its Jolen Creme Bleach hair formula. The company said Monday that Jolen Creme Bleach retains its iconic logo and package color but sports a new package design to freshen up the brand’s look.
Rite Aid creates online destination for vaccinations
The findings of a national consumer survey on immunizations has led Rite Aid Corp. to launch Vaccine Central, a new online platform to raise awareness about vaccines and promote vaccinations. A key resource of the new Vaccine Central site is an immunization assessment tool.
Report: Retail chains up the ante in specialty pharmacy
Specialty pharmacy operators can expect to see escalating competition from retail pharmacy chains, which are rapidly expanding their specialty drug services, according to a study from Healthcare Research & Analytics (HRA).